Gerald Batist
McGill University
H-index: 69
North America-Canada
Top articles of Gerald Batist
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Discovery of a smart molecular glue: A small-molecular compound selectively degrades Nrf2 in KEAP1-mutated tumor cells, by restoring the broken KEAP1 mutant/Nrf2 interaction | Cancer Research | Xiaohong Tian Tahar Aboulkassim Qiang Liu Mark Hancock Jian Hui Wu | 2024/3/22 |
Progression-free survival gain: A reliable primary end point for drug registration that can accelerate patient access to urgently needed therapies | Journal of clinical oncology: official journal of the American Society of Clinical Oncology | David J Stewart Tim Ramsay Vishal Navani Geoffrey Liu Di Maria Jiang | 2024/1/30 |
The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers | Cancers | Suzanne Kazandjian Emmanuelle Rousselle Matthew Dankner David W Cescon Anna Spreafico | 2024/1/19 |
New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices | Current Oncology | David J Stewart John-Peter Bradford Sandeep Sehdev Tim Ramsay Vishal Navani | 2024/4/28 |
Brief Report: Impact of anti-cancer treatments on outcomes of COVID-19 in patients with thoracic cancers: a CCC19 registry analysis | Clinical Lung Cancer | Amit A Kulkarni Cassandra Hennessy Grace Wislon Vidhyalakshmi Ramesh Clara Hwang | 2024/4/10 |
SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain | Oncogene | Qianhui Yi Xiaojun Han Henry G Yu Huei-Yu Chen Dinghong Qiu | 2024/3/26 |
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology | Therapeutic Advances in Medical Oncology | Vladimir Lazar Baolin Zhang Shai Magidi Christophe Le Tourneau Eric Raymond | 2023/3 |
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19 | JAMA oncology | Shuchi Gulati Chih-Yuan Hsu Surbhi Shah Pankil K Shah Rebecca Zon | 2023/10/1 |
Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategies. | bioRxiv | Georgia Mitsa Livia Florianova Josiane Lafleur Adriana Aguilar-Mahecha Rene P Zahedi | 2023 |
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase | 2023/9/28 | ||
A NRF2 inhibitor selectively sensitizes KEAP1 mutant tumor cells to cisplatin and gefitinib by restoring NRF2-inhibitory function of KEAP1 mutants | Cell Reports | Tahar Aboulkassim Xiaohong Tian Qiang Liu Dinghong Qiu Mark Hancock | 2023/9/26 |
Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 | JAMA oncology | Ziad Bakouny Chris Labaki Punita Grover Joy Awosika Shuchi Gulati | 2023/1/1 |
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy | International Journal of Molecular Sciences | Karen Gambaro Maud Marques Suzan McNamara Mathilde Couetoux du Tertre Cyrla Hoffert | 2023/12/19 |
Quantitation of the PD-1/PD-L1 axis in non-small cell lung cancer by immuno-multiple reaction monitoring. | Vincent Lacasse Rene P Zahedi Vincent R Richard Hangjun Wang Georgia Mitsa | 2023/6/1 | |
Abstract CT035: Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival | Cancer Research | Petr Kavan Daniel A Saltzman Jule Muegge Jordan Moradian Gerald Batist | 2023/4/14 |
Lasofoxifene versus fulvestrant for ER+/HER2− metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial | Annals of Oncology | MP Goetz NA Bagegni G Batist A Brufsky MA Cristofanilli | 2023/12/1 |
A non-hazardous deparaffinization protocol enables quantitative proteomics of core needle biopsy-sized Formalin-Fixed and Paraffin-Embedded (FFPE) tissue specimens | International Journal of Molecular Sciences | Georgia Mitsa Qianyu Guo Christophe Goncalves Samuel EJ Preston Vincent Lacasse | 2022/4/18 |
743P A phase Ib dose escalation study of CD137 mAb agonist OC-001 as monotherapy in patients with advanced or metastatic cancer | Annals of Oncology | WH Miller D Provencher QS-C Chu D Jonker AM Oza | 2022/9/1 |
Predicted long‐term impact of COVID‐19 pandemic‐related care delays on cancer mortality in Canada | International journal of cancer | Talía Malagón Jean HE Yong Parker Tope Wilson H Miller Jr Eduardo L Franco | 2022/4/15 |
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From … | JCO Precision Oncology | Vladimir Lazar Nicolas Girard Eric Raymond Jean-François Martini Susan Galbraith | 2022/9 |
